ED vs GRCE · P/E 18, rev $15.26B vs $35.0M cap
Consolidated Edison Inc (ED) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
GRCE does not have a complete income-statement cache yet.
ED currently screens at market cap $36.02B and trailing P/E 18.3. GRCE currently screens at market cap $35.0M.
Not investment advice. Open the ED and GRCE stock pages for the full models.
Not investment advice.